These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 3007264)
61. [Treatment of motor urge incontinence with the beta 2-sympathomimetic drug clenbuterol (author's transl)]. Grüneberger A; Geier G Urologe A; 1981 May; 20(3):153-4. PubMed ID: 6115496 [TBL] [Abstract][Full Text] [Related]
62. [Clinical effects of clenbuterol-HCL in urge incontinence and stress incontinence]. Yamanishi T; Yasuda K; Nagashima K; Naoto ; Murayama ; Tojo M; Shimazaki J Hinyokika Kiyo; 1990 Feb; 36(2):207-11. PubMed ID: 2343815 [TBL] [Abstract][Full Text] [Related]
63. [Treatment of urgency incontinence using the beta-mimetic, clenbuterol]. Martan A; Sindlár M; Halaska M; Koleska T; Stulc B Cesk Gynekol; 1986 Aug; 51(7):535-9. PubMed ID: 3757080 [No Abstract] [Full Text] [Related]
64. Treatment of motor urge incontinence with clenbuterol and flavoxate hydrochloride. Grüneberger A Br J Obstet Gynaecol; 1984 Mar; 91(3):275-8. PubMed ID: 6367811 [TBL] [Abstract][Full Text] [Related]
65. [Treatment of urinary urgency symptoms in the female with the beta-2-sympathomimetic clenbuterol]. Voigt R; Martan A; Halaska M; Sindlar M; Voigt P Geburtshilfe Frauenheilkd; 1986 Feb; 46(2):115-7. PubMed ID: 3007264 [TBL] [Abstract][Full Text] [Related]
66. [Recommendations for the urodynamic examination in the investigation of non-neurological female urinary incontinence]. Hermieu JF; Prog Urol; 2007 Nov; 17(6 Suppl 2):1264-84. PubMed ID: 18214138 [TBL] [Abstract][Full Text] [Related]
67. Selective beta-adrenoceptor agonists, calcium antagonists and potassium channel openers as a possible medical treatment of the overactive bladder and urge incontinence. Badawi JK; Langbein S Pharmazie; 2006 Mar; 61(3):175-8. PubMed ID: 16599254 [TBL] [Abstract][Full Text] [Related]